NCT05903924

Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

Motion Serifos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 316 (actual)
• Sponsor: Vanda Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel

Conditions

• Motion Sickness

Interventions

Type	Name	Description
DRUG	Tradipitant	Oral Capsule
DRUG	Placebo	Oral Capsule

Timeline

• Start date: 2023-09-09
• Primary completion: 2024-04-06
• Completion: 2024-04-24
• First posted: 2023-06-15
• Last updated: 2025-04-04
• Results posted: 2025-04-04

Locations

5 sites across 1 country: United States

Regulatory

• FDA-regulated drug study